drugIndia
Cart
Gliris-MV 1 Tablet SR

Gliris-MV 1 Tablet SR

Metformin (500mg) + Glimepiride (1mg) + Voglibose (0.2mg)

Bioiris Pharmaceuticals Pvt Ltd
Anti-Vomiting
114.00142.5020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 72%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Gliris-MV 1 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹82

that's 72% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
114.0020% OFF
142.50

About This Medicine

Product description & overview

Gliris-MV 1 Tablet SR: A Combined Diabetes Treatment Solution

Gliris-MV 1 Tablet SR is a once-daily oral formulation containing three vital components for effective diabetes management: Glimepiride (1mg), Metformin (500mg) and Voglibose (0.2mg). This combination therapy addresses multiple mechanisms of action in blood sugar regulation, making it suitable for individuals with type 2 diabetes.

Glimepiride: A sulfonylurea medication that increases insulin secretion from the pancreas, promoting efficient glucose utilization.
Metformin: A biguanide that reduces hepatic glucose production and enhances peripheral glucose uptake. It plays a crucial role in lowering blood sugar levels in patients with type 2 diabetes.
Voglibose: An α-glucosidase inhibitor that slows down the digestion of carbohydrates, preventing rapid post-meal glucose spikes.

Gliris-MV 1 Tablet SR offers a comprehensive approach to managing blood glucose fluctuations, ensuring optimal control and a more manageable lifestyle for individuals living with diabetes. This formulation is available in convenient single-dose tablets, simplifying patient convenience.

Please consult your healthcare professional before starting any new medication regimen.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Gliris-MV 1 Tablet SR.

High Risk

Pregnancy

Gliris-MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Gliris-MV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Gliris-MV 1 Tablet SR may be needed. Please consult your doctor. Gliris-MV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Gliris-MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Gliris-MV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Gliris-MV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Gliris-MV 1 Tablet SR

Products matching your search